Kim has extensive experience leading strategic engagements across the life sciences industry. In that context, she has helped pharma and biotech companies tackle a diverse range of strategic issues across the product lifecycle, with a specific interest in launch preparation and planning. Kim additionally has deep expertise across therapeutic areas, with a more recent emphasis within rare diseases, hematology/oncology, and cardiovascular/metabolic diseases. Kim is energized by forming collaborative partnerships with clients, helping them craft impactful and actionable solutions to their most pressing challenges.
Kim leverages 10+ years of experience in the life sciences, including translational clinical research at Massachusetts General Hospital prior to joining Clearview. She has spent the majority of her career specifically focused on growth strategy in the life sciences industry, supporting executives at the brand, therapeutic area, and corporate level. Kim earned her B.A. in History of Science from Harvard University.
Debbi Amanti Belanger
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
Kim Goh
Ketan Kapadia
Philip Kenner
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Jim Caruso
Steve Rubman
Lainey Miller
Brian Gibbs
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Dave Konciak
Charles Mathews
Rohit Kumar
Mike Roy
Beko Binder
Jessica Berard
Peter Goldman
Maneesh Gujrati
Austin Hubbert
Jonny Juliano
Owen Im
Andrew Kang
Patrick Kuettner
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian
Vini De Nadai